Xilaplus® launched in France by Therabel

Noventure is proud to announce the launch of XILAPLUS® in France by its long-term partner company Therabel, under the brand name Diastil Diarrhée.

XILAPLUS® is specifically formulated for the control and reduction of diarrheal events of various etiologies. It acts by forming a film which protects the intestinal mucosa, reducing the frequency and duration of diarrhea episodes and associated symptoms in adults, children, and infants.

XILAPLUS® is a class III medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments (CE 0373, Noventure SL). It is already successfully marketed in Spain and Sweden and we expect a strong uptake in the large French market